Chemoprevention: Will it work?

International Journal of Cancer

Volumn 71, Issue SUPPL. 10, 1997, Pages 18-21

  Mettlin, Curtis ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIESTROGEN; ASCORBIC ACID; BETA CAROTENE; FINASTERIDE; IBUPROFEN; ISOTRETINOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PLACEBO; RETINOL; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMOXIFEN; ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER PREVENTION; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; LEUKOPLAKIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TREATMENT OUTCOME; VITAMIN INTAKE; BREAST TUMOR; COLORECTAL TUMOR; HEAD AND NECK TUMOR; LUNG TUMOR; NEOPLASM; PROSTATE TUMOR; REVIEW;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 0030630766     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(1997)10+<18::aid-ijc6>3.0.co;2-c     Document Type: Article

References (35)

1. ALBERTS, D.S. and 12 OTHERS, Randomized, double-blinded, placebocontrolled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected colon polyps. J. nat. Cancer lust., 88, 81-92 (1996).
2. ALPHA-TOCOPHEROL, BETA-CAROTENE CANCER PREVENTION STUDY GROUP, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl. J. Med., ., 330, 1029-1035 (1994).
3. BJELKE, E., Dietary vitamin A and human lung cancer. Int. J. Cancer, 15, 561-567(1975).
4. BOLOGNA, M., Muzi, P., BIORDI, L., FESTUCCIA, C. and VICENTINI, C, Antiandrons and 5-alpha reductase inhibition of the proliferation rate in PC3 and DU145 human prostatic cancer cell lines. Curr. Ther. Res., ., 51, 799-813 (1992).
5. BRAUN, M.M., HELZLSOUER, K.J., HOLLIS, B.W. and COMSTOCK, G.W., Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control, 6,235-239 (1995).
6. CORDER, E.H., GUESS, H.A., HULKA, B.S., FRIEDMAN, G.D., SADLER, M., VOLLMER, R.T., LOBAUGH, B. and DREZNER, M.K., Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol. Biomarkers Pre\:, 2,467-472 (1993).
7. DECOSSE, J.J., MILLER, H.H. and LESSER, M.L., Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis.y. nal. Cancer lust., ., 81, 1290-1297 (1989).
8. GIOVANNUCCI, E.,ASHERIO,A., RlMM, E.B., STAMPFER, M.J., COLDITZ, G.A. and WILLETT, W., Intake of carotenoids and retinol in relation to risk of prostate cancer. J. not. Cancer Inst., ., 87, 1767-1776(1995).
9. GREENWALD, P., Preventive clinical trials: an overview. Ann. N. Y. Acad. Sci., ., 768,129-140(1995).
10. HANCHETTE, C.L. and SCHWARTZ, G.G., Geographic patterns of prostate cancer mortality. Cancer, 70,2861-2869 (1992).
11. HEATH, C.W., THUN, M.J., GREENBERO, E.R., LEVIN, B. and MARNETT, L.J., Nonsteroidal antiinflammatory drugs and human cancer: report of an interdisciplinary research workshop. Cancer, 74,2885-2888 (1994).
12. HENNEKENS, C.H., BURING, J.E., MANSOM, J.E., STAMPFER, M., ROSNER, B., COOK, N.R., BELANGER, C., LAMOTTE, F., GAZIANO, J.M., RIDKER, P.M., WILLETT, W. and PETO, R., Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New Engl. J. Med., ., 334, 1145-1149 (1996).
13. HIRAYAMA, T., Diet and cancer. Nulr. Cancer, 1,67-72 (1979).
14. HONG, W.K. and 14 OTHERS, 13-c/>retinoic acid in the treatment of oral leukoplakia. New Engl. J. Med., ., 315,1501-1505 (1986).
15. HONG, W.K. and 12 OTHERS, Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. New Engl. J. Med., ., 323,795-800 (1990).
16. KADOHAMA, N., KARR, J.P., MURPHY, G.P. and SANDBERG, A.A., Selective inhibition of prostatic tumor 5-alpha-reductase by a 4-methy 1-4-aza-steroid. Cancer Res., ., 44,4947-1954 (1984).
17. KUNE, G., KUNE, S. and WATSON, L.F., Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res., ., 48,4399-M04 (1988).
18. LIPPMAN, S.M., BENNER, S.E. and HONG, W.K., Chemoprevention: strategies for the control of cancer. Cancer, 72,984-990 (1993).
19. MACLENNAN, R., DACOSTA, J., DAY, N.E., LAW, C.H., No, Y.K. and SHANMUGARATNAM, K., Risk factors for lung cancer in Singapore Chinese, a population with high female incidence rates. Int. J. Cancer, 20, 854-860 (1977).
20. MAYNE, ST., ZHENG, T.Z., JANERICH, D.T., GOODWIN, W.J., JR., FALLON, E.G., COOPER, D.L. and FRIEDMAN, C.D., A population-based trial of beta carotene Chemoprevention of head and neck cancer. Adv. e.\p. Med. BioL, 320,119-127(1992).
21. MCKEOWN-EYSSEN, G., HOLLOWAY, C., JAZMAJI, V., BRIGHT-SEE, E., DlON, P. and BRUCE, W.R., A randomized trial of vitamins C and E in the prevention of recurrence of Colorectal polyps. Cancer Res., ., 48,4701-1705 (1988).
22. METTLIN, C, Milk drinking, other beverage habits and luna cancer risk. Int. J. Cancer, 43,608-612 ( 1989).
23. METTLIN, C., GRAHAM, S. and SWANSON, M., Vitamin A and lung cancer. J. not. Cancer Inst., ., 62,1435-1438 (1979).
24. NIXON, D.W., Special aspects of cancer prevention trials. Cancer, 74, 2683-2686(1994).
25. OMENN, G.S., GOODMAN, G.E., THORNQUIST, M.D., BALMES, J., CULLEN, M.R., GLASS, A., KEOUGH, J.P., MEYSKENS, F.L., JR., VALANIS, B., WILLIAMS, J.H., JR., BARNHART, S. and HAMMAR, S., Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl. J. Med., ., 334,1150-1155 (1996).
26. PAGANINI-HILL, A., Hsu, G., Ross, R.K. and HENDERSON, B.E., Aspirin use and incidence of large-bowel cancer in a California retirement community. J. nat. Cancer Inst., ., 83, 1247-1250 (1991).
27. ROSE, O.P., BOYAR, A.P. and WYNDER, E.L., International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon and per capita food consumption. Cancer, 58,2363-2371 (1986).
28. ROSENBERG, L., PALMER, J.R., ZAUBER, A.G., WARSHAUER, M.E., STOLLEY, P.D. and SHAPIRO, S., A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. nat. Cancer Inst., ., 83, 355-358(1991).
29. Ross, R., BERNSTEIN, L., JUDD, H., MANISCH, R., PIKE, M. and HENDERSON, B., Serum testosterone levels in healthy young black and white men. J. nat. Cancer Inst., ., 76,45-48 (1986).
30. Ross, R.K., BERNSTEIN, L., LOBO, R.A., SHIMIZU, H., STANCZYK, F.Z., PIKE, M.C. and HENDERSON, B.E., 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet, 339, 887-889(1992).
31. STONER, E. and the FINASTERIDE STUDY GROUP, The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. J. Urol., ., 147,1298-1302(1992).
32. SUH, O., METTLIN, C. and PETRELLI, N., Aspirin use, cancer and polyps of the large bowel. Cancer, 72, 1171-1177 (1993).
33. THOMPSON, I., FEIGL, P. and COLTMAN, C., Chemoprevention of prostate cancer with finasteride. In: V.T. De Vita, Jr., S. Hellman and S.A. Rosenberg (eds.). Important Advances in Oncology, pp. 57-76, J.B. Lippincott, Philadelphia (1996).
34. THUN, M.J., NAMBOODIRI, M.M. and HEATH, C.W., JR., Aspirin use and reduced risk of fatal colon cancer. New Engl. J. Med., ., 325, 1593-1596 (1991).
35. WILLETT, W.C., STAMPFER, M.J., COLDITZ, G.A., ROSNER, B.A., HENNEKENS, C.H. and SPEIZER, F.E., Dietary fat and the risk of breast cancer. New Engl. J.Med., ., 316,22-28 (1987).